Analysis of Uric Acid and other Factors affecting Renal Function in the Monitoring of Renal Transplant Recipients

    loading  Checking for direct PDF access through Ovid

Abstract

Introduction

The two major factors associated with long-term renal allograft loss continue to be death with a functioning graft and chronic allograft nephropathy (CAN). Numerous risk factors for graft injury have been identified as possible contributors to CAN including: acute injury and chronic injury factors.

Introduction

The aim of this study is to identify the clinical factors that impact graft function in renal transplant recipients.

Methods

This was a retrospective cohort study using the medical records of 120 patients attending the outpatient transplant clinic for the period January 2012 to January 2014.

Methods

The patients were followed up at three monthly intervals for a total of 24 months.

Methods

Socio-demographic and clinical characteristics were recorded.

Methods

Data analysis using SPSS version 24 (IBM) comprised of descriptive tests and linear regression analysis (expressed as OR (odd ratio) and confidence interval) for the study of the association of above characteristics with patients’ outcome.

Methods

Linear regression analysis was performed using difference in serum creatinine (Creatinine at visit 9 minus creatinine at visit 1) and age, gender, BMI, race, proteinuria, ACEI, cholesterolaemia and hyperuricaemia, non-dihydropyridine calcium channel blockers (NCCB).

Results and Discussion

Linear regression analysis of change in serum creatinine and uric acid performed showed a high uric acid at baseline was associated with significant decline in serum creatinine (p value 0.025).

Results and Discussion

Linear regression analysis showed NDCCB had a protective effect on serum creatinine (p value 0.02).

Results and Discussion

Multivariate linear regression analysis of worsening renal function in the presence of two variables NDCCB and CNI showed that NDCCB protective effect was dependent on patients being on CNI treatment and the protective effects of CNI was independent of NDCCB use(p value 0.002).

Results and Discussion

Logistic regression analysis of change in serum creatinine in CNI vs Sirolimus showed CNI use was associated with less decline in serum creatinine vs sirolimus (p value 0.006), however most patients were started on a CNI first and converted to sirolimus.

Conclusion

Our study suggested that an elevated uric acid at baseline was associated with decline in serum creatinine in allograft recipients over a 2 year period. While NDCCB had a protective effect, this was limited to patients on calcineurin inhibitors.

Related Topics

    loading  Loading Related Articles